Results for tag: "Temoporfin"

Temoporfin is a photosensitizing drug used in oncology to treat certain types of cancer. It is administered intravenously and works by targeting cancer cells with light-activated chemotherapy. The drug is used in photodynamic therapy (PDT), a minimally invasive procedure that uses light to activate the drug and destroy cancer cells. Temoporfin is used to treat a variety of cancers, including head and neck, esophageal, bladder, and skin cancers. It is also used to treat non-cancerous conditions such as age-related macular degeneration. The temoporfin market is growing due to the increasing prevalence of cancer and the growing demand for minimally invasive treatments. The rising awareness of PDT and its advantages over traditional treatments is also driving the market. The increasing number of clinical trials and the availability of generic versions of the drug are also contributing to the growth of the temoporfin market. Some companies in the temoporfin market include Novartis, Merck, Pfizer, and Allergan. Show Less Read more